Skip to content

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Long-Term Safety and Efficacy Extension Study Of Autologous Adipose-Derived Mesenchymal Stem Cells 『JOINTSTEM』 in Patients With Knee Osteoarthiritis: A Phase III Extension Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04427930
Enrollment
129
Registered
2020-06-11
Start date
2020-04-13
Completion date
2027-12-30
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

Interventions

BIOLOGICALJOINTSTEM

Autologous Adipose Tissue derived MSCs

Sponsors

R-Bio
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants of Jointstem Phase 3 Clinical Trial * Participates who signed informed consent document of this study

Exclusion criteria

* No applicable

Design outcomes

Primary

MeasureTime frameDescription
Adverse Events5 YearsIncidence of adverse events from baseline to 5 Years

Secondary

MeasureTime frameDescription
WOMAC 3 subscale score5 YearsPain, stiffness, and physical function of the knee will be measured by the Western Ontario and McMaster Universities (WOMAC)
SF-365 YearsThe SF(Short Form)-36 Health Survey is a 36-item, patient-reported survey of patient health.
Measuring of Kellgren-Lawrence grade1, 2, 3, 4, 5 YearsMeasuring of Kellgren-Lawrence grade through X-ray
Change of Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) scores from baseline5 YearsPain, stiffness, and physical function of the knee will be measured by the WOMAC score
Measuring of Hip-Knee-Ankle angle(HKA)1, 2, 3, 4, 5 YearsMeasureing of HKA through X-ray
Measuring of Joint Space Width1, 2, 3, 4, 5 Yearsmeasuring Joint Space Width through X-ray
MRI scan1, 2, 3, 4, 5 YearsThe cartilage defect area is measured using MRI
Measuring of Femoro-tibial anatomical angle(FTA)1, 2, 3, 4, 5 YearsMeasuring of FTA through X-ray

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026